American International Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,926
Closed -$592K 3011
2024
Q1
$592K Sell
16,926
-145
-0.8% -$5.29K ﹤0.01% 1567
2023
Q4
$649K Sell
17,071
-69
-0.4% -$1.48K ﹤0.01% 1518
2023
Q3
$315K Buy
17,140
+610
+4% +$12.8K ﹤0.01% 1867
2023
Q2
$429K Buy
16,530
+806
+5% +$18.8K ﹤0.01% 1737
2023
Q1
$297K Buy
15,724
+313
+2% +$7.28K ﹤0.01% 1888
2022
Q4
$380K Buy
15,411
+1,552
+11% +$45.6K ﹤0.01% 1756
2022
Q3
$249K Buy
13,859
+195
+1% +$3.52K ﹤0.01% 2035
2022
Q2
$155K Sell
13,664
-195
-1% -$2.87K ﹤0.01% 2351
2022
Q1
$309K Sell
13,859
-976
-7% -$24.9K ﹤0.01% 1989
2021
Q4
$648K Sell
14,835
-443
-3% -$17.7K ﹤0.01% 1652
2021
Q3
$509K Sell
15,278
-364
-2% -$11.1K ﹤0.01% 1844
2021
Q2
$430 Buy
15,642
+10,905
+230% +$227K ﹤0.01% 2021
2021
Q1
$95 Buy
4,737
+12
+0.3% +$350 ﹤0.01% 2751
2020
Q4
$156 Buy
+4,725
New +$126K ﹤0.01% 2417

Other funds holding INBX

American International Group's INBX Position: Q2 2024 in Review

American International Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 16,926 shares — an estimated $592K sold.

American International Group first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $649K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • American International Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 16,926 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $592K.
  • American International Group first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • American International Group's Inhibrx, Inc. Common Stock position peaked at $649K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.